Ramana Naidu, MD
Pain Medicine · Larkspur, CANPI 1164678512
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $840,093 of the $1,377,866 with a category attached, or 61.0%. 37 manufacturers reported payments, led by Boston Scientific at 43.0% of the total. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,206 payments — averaging $624.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$593K
- Relievant Medsystems, Inc.$181K
- Abbott$129K
- Vertiflex, Inc.$111K
- Biotronik NRO, Inc.$88K
- Spinal Simplicity, LLC$76K
- plus $201K from 31 others
Across 90 payments — averaging $2939.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$220K
- Abbott$35K
- Bioventus LLC$4K
- Vertiflex, Inc.$3K
- Nalu Medical, Inc.$2K
- Saluda Medical Americas, Inc.$156
Across 3 payments — averaging $3782.93 each. An ownership or investment interest held by the physician or an immediate family member.
- Spinal Simplicity, LLC$11K
What the payments were for
- Consulting fees$315,22423%
- Speaking & faculty fees$840,09361%
- Travel & lodging$123,1449%
- Food & beverage$78,3936%
- Education$16,2291%
- Entertainment$4200%
- Ownership interest$4,3640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 777 | $592,673 |
| Relievant Medsystems, Inc. | 220 | $180,670 |
| Abbott | 435 | $129,082 |
| Vertiflex, Inc. | 127 | $110,788 |
| Biotronik NRO, Inc. | 205 | $88,382 |
| Spinal Simplicity, LLC | 14 | $75,688 |
| Avanos Medical | 62 | $43,320 |
| Painteq LLC | 100 | $34,472 |
| SPR Therapeutics, Inc | 48 | $30,926 |
| Bioventus LLC | 57 | $20,835 |
| Nalu Medical, Inc. | 23 | $19,637 |
| Ferring Pharmaceuticals Inc. | 17 | $14,857 |
| Omnia Medical, LLC | 4 | $10,500 |
| Biotronik Inc. | 6 | $7,075 |
| Vertos Medical, Inc. | 20 | $4,362 |
| Stratus Medical, LLC | 7 | $3,062 |
| Brixton Biosciences, Inc. | 6 | $2,812 |
| Medtronic(2 entities) | 17 | $2,747 |
| Si-bone, Inc. | 8 | $1,448 |
| Stryker | 11 | $1,082 |
| Alphatec Spine, Inc | 16 | $931 |
| GS Solutions, Inc. | 1 | $651 |
| Corelink, LLC | 5 | $501 |
| Bioness Inc | 1 | $420 |
| Surgalign Spine Technologies, Inc. | 3 | $204 |
| Curonix LLC | 2 | $185 |
| Saluda Medical Americas, Inc. | 3 | $113 |
| Johnson & Johnson(2 entities) | 2 | $76 |
| Carlsmed, Inc. | 1 | $67 |
| Stimwave Technologies Incorporated | 1 | $62 |
| MML US, Inc. | 1 | $49 |
| Globus Medical | 1 | $39 |
| Foundation Fusion Solutions, LLC | 1 | $36 |
| Moximed, Inc | 1 | $35 |
| Zavation Medical Products, LLC | 1 | $29 |
| Nevro Corp. | 1 | $25 |
| Biocomposites Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$582,169
- SUPERION$179,295
- Superion Indirect Decompression System$136,469
- Superion ISS$108,396
- HA MINUTEMAN G3-R$75,452
- Prospera$73,642
- Neuromodulation Dspsbls and Accs$59,893
- COOLIEF$37,850
- GENERAL - THERAPIES$33,234
- PAINTEQ$31,187
- SPRINT PNS System$29,861
- PROCLAIM$22,797
- Nalu Neurostimulation System$19,415
- Stimrouter Implantable Kit$19,388
- VERIFLEX$16,388
- Proclaim Family of SCS IPGs$15,721
- WaveWriter Alpha Prime 16$13,818
- Prodigy Family of SCS IPGs$7,923
- BIOTRONIK$7,536
- GENERAL PAIN MANAGEMENT$6,376
How this compares
$1,377,866 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 53 | $441 |
| Baclofen | 16 | $377 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $263 |
| Celecoxib | 13 | $188 |
| Gabapentin | 16 | $164 |
| Amitriptyline Hcl | 12 | $154 |
| Lorazepam | 15 | $27 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Larkspur
- Jason PopeSanta Rosa$2.1M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
- Einar OttestadStanford$352K
- Shveta JainFullerton$351K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.